CDTX
Cidara Therapeutics
CDTX
CDTX
Delisted
CDTX was delisted on the 6th of January, 2026.
109 hedge funds and large institutions have $1.26B invested in Cidara Therapeutics in 2025 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
137% more funds holding
Funds holding: 46 → 109 (+63)
34.05% more ownership
Funds ownership: 87.3% → 121.35% (+34%)
58% less call options, than puts
Call options by funds: $38M | Put options by funds: $90.5M
Holders
109
Holding in Top 10
9
Calls
$38M
Puts
$90.5M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$43.2M | |
| 3 | +$34M | |
| 4 |
CC
Commodore Capital
New York
|
+$28.2M |
| 5 |
BlackRock
New York
|
+$25.3M |
Top Sellers
| 1 | -$9.91M | |
| 2 | -$6.91M | |
| 3 | -$3.32M | |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
-$2.25M |
| 5 |
Millennium Management
New York
|
-$1.37M |